Duetact

Active Ingredient(s): Glimepiride + Pioglitazone Hydrochloride
FDA Approved: * July 28, 2006
Pharm Company: * TAKEDA GLOBAL
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Duetact Overview

Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea,[1] or as second-generation.[2] Contents 1 Indications 2 Contraindications 3 Adverse effects 4 Pharmacokinetics 5 Mechanism of action 6 Interactions 7 References 8 External links Indications Main article: Sulfonylurea Glimepiride is indicated to treat type 2 di...

Read more Duetact Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Glimepiride

Recent Duetact Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Duetact: (2 results)

Sorted by National Drug Code

• 64764-302 Duetact 30/2 mg Oral Tablet by Takeda Pharmaceuticals America, Inc.
• 64764-304 Duetact 30/4 mg Oral Tablet by Takeda Pharmaceuticals America, Inc.

Drugs with one or more similar ingredients: (9 results)

• GLIMEPIRIDE + PIOGLITAZONE HYDROCHLORIDE
• ACTOPLUS MET Metformin + Pioglitazone Hydrochloride2 discussions
• ACTOPLUS MET XR Pioglitazone Hydrochloride + Metformin Hydrochloride
• AMARYL Glimepiride28 discussions
• AVANDARYL Glimepiride + Rosiglitazone Maleate2 discussions
• GLIMEPIRIDE 86 discussions
• GLIMEPIRIDE + ROSIGLITAZONE MALEATE
• METFORMIN + PIOGLITAZONE HYDROCHLORIDE 1 discussion
• PIOGLITAZONE HYDROCHLORIDE + METFORMIN HYDROCHLORIDE 1 discussion